Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.75 |
| ▸ | ECE1 | P42892 | 12/20 | 0.72 |
| ▸ | CTSC | P53634 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valyltryptophan SCHEMBL150532 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30821963 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30821897 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL29365770 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051305 | 0.98 | ACE (0.72) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051858 | 0.96 | ACE (0.69) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051553 | 0.95 | ACE (0.68) | ACEECE1CTSCALOX15 | |
| SCHEMBL30052892 | 0.94 | ACE (0.67) | ACEECE1CTSC | |
| Hydrochloric Acid SCHEMBL11229707 | 0.94 | ACE (0.67) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30641543 | 0.94 | ACE (0.67) | ACEECE1CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747264-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | University of Reading (GB) | 2026-05-27 | — | — | EP | claimed |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| WO-2025037123-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | UNIVERSITY OF READING (GB) | 2025-02-20 | — | — | WO | claimed |
| CN-118987163-A | Use of sardine peptide-containing composition for improving atopic dermatitis symptoms | 海口桥水联合科技有限责任公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| US-20240342237-A1 | COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION | Xygenyx Inc. | 2024-10-17 | — | — | US | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-116350746-B | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| EP-4310093-A1 | AMINO ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS, COMPRISING SAME | Prazertherapeutics Inc. (KR) | 2024-01-24 | — | — | EP | claimed |
| CN-115397836-A | Novel antibacterial peptide and application thereof | 安尼根有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2022196858-A1 | AMINO ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS, COMPRISING SAME | (주)프레이저테라퓨틱스 | 2022-09-22 | — | — | WO | claimed |
| CN-114634547-A | Dipeptide-2 synthesis process | 山东济肽生物科技有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-101795732-A | Magnolia extract containing compositions | MARY KAY INC | 2010-08-04 | — | — | CN | claimed |
| EP-2144673-A2 | MAGNOLIA EXTRACT CONTAINING COMPOSITIONS | Mary Kay, Inc. (US) | 2010-01-20 | — | — | EP | claimed |
| WO-2008130752-A2 | MAGNOLIA EXTRACT CONTAINING COMPOSITIONS | MARY KAY INC. (US) | 2008-10-30 | — | — | WO | claimed |
| US-20080260869-A1 | Topical skin care; Magnolia extract and other botanical extracts; telangiectasia, puffy eyes, fine lines or wrinkles; reduces or inhibits new capillary formation in or near the treated skin | MARY KAY INC. (US) | 2008-10-23 | — | — | US | claimed |
| EP-0084941-B1 | AMIDE DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-03-11 | — | — | EP | claimed |
| US-4528282-A | Amide derivatives | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1985-07-09 | — | — | US | claimed |
| EP-0084941-A1 | Amide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-08-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080260869-A1 | Topical skin care; Magnolia extract and other botanical extracts; telangiectasia, puffy eyes, fine lines or wrinkles; reduces or inhibits new capillary formation in or near the treated skin | CUTA, HIRA, VEGFA | ACE 2946/4885ECE1 1658/4885CTSC 941/4885 |
| US-20240342237-A1 | COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION | CUTA, PHLPP1, PHLPP2 | ACE 4046/4885ECE1 1737/4885CTSC 249/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | ACE 132/4885ECE1 363/4885CTSC 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.